# Pelthos Therapeutics Shares Fall About 35% After Castle Creek Merger Deal

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/44881
Published: 2026-10-30T16:20:48.000Z
Updated: 2026-10-30T16:20:48.000Z
Section: Business

> The reported share price was $10.79. The proposed combination would add cell and gene therapies for serious skin diseases to Pelthos’ portfolio.

Pelthos Therapeutics Inc. (PTHS) shares were at $10.79 Friday, Oct. 30, down about 35% after the company agreed to combine with Castle Creek Biosciences (CCBS).

The proposed deal would broaden Pelthos’ portfolio with cell and gene therapies aimed at serious skin diseases.